Dermatology

ANAPTYSBIO, INC

12/9/21 → 12/31/26

Project: Research project

A MULTICENTER, OPEN-LABEL, EXTENSION STUDY TO ASSESS THE LONGTERM SAFETY ANDEFFICACY OF CTP-543 IN ADULT PATIENTS WITHMODERATE TO SEVERE ALOPECIA AREATA

Concert Pharmaceuticals, Inc.

5/20/21 → 5/31/26

Project: Research project

A STUDY TO EVALUATE MAINTENANCE OF HAIR REGROWTH FOLLOWINGDOSE REDUCTION OF CTP-543 IN ADULT PATIENTS WITH MODERATE TOSEVERE ALOPECIA AREATA

Concert Pharmaceuticals, Inc.

3/1/21 → 3/30/26

Project: Research project

An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1904to Evaluate the Safety, Tolerability, and Efficacy of EfgartigimodPH20 SC in Patients With Pemphigus

Argenx

9/17/20 → 9/30/25

Project: Research project

A Randomized, Double-Blinded, Double-Dummy, Active-Comparator Trial to Investigate the Efficacy,Safety, and Tolerability of Efgartigimod PH20 SC Compared to Rituximab in Adult Patients with Moderateor Severe Pemphigus (Vulgaris or Foliaceus)

Argenx

8/19/20 → 8/30/25

Project: Research project

A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CTP-543 IN ADULT PATIENTS WITH MODERATE TO SEVERE ALOPECIA AREATA

Concert Pharmaceuticals, Inc.

5/1/20 → 7/30/25

Project: Research project

A Phase 3, Multicenter, Open-Label Extension Study of Patidegib Topical Gel, 2% in Subjects with Gorlin Syndrome (Basal Cell Nevus Syndrome)

Maher, I.

PELLEPHARM, INC.

5/18/20 → 5/31/25

Project: Research project

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 24-Week Study, with a 28-Week Open-Label Extension, to Assess the Safety and Efficacy of Etrasimod in Subjects with Moderate-to-Severe AlopeciaAreata

ARENA PHARMACEUTICALS, INC.

5/14/20 → 5/31/25

Project: Research project

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Immune-MediatedInflammatory Skin Conditions

TARGET PHARMASOLUTIONS, INC

4/6/20 → 4/30/25

Project: Research project

PHASE 2 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF PF-06823859 IN ADULT SUBJECTS WITH DERMATOMYOSITIS

Pearson, D. R.

1/19/21 → 1/31/25

Project: Research project

A PHASE 2A, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 16-WEEK STUDY EVALUATING THE SAFETY AND EFFICACY OF PF-06650833, PF-06700841, AND PF-06826647 IN ADULTS WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA

Goldfarb, N.

1/10/20 → 1/30/25

Project: Research project

Coordinating Investigator Agreement

Pearson, D. R.

EMD Serono, Inc.

11/1/21 → 11/1/24

Project: Research project

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group,Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan inSubjects with Moderate to Severe Hidradenitis Suppurativa

Goldfarb, N.

ChemoCentryx, Inc.

8/1/19 → 8/30/24

Project: Research project

A Phase 2, Multicenter,Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Risankizumab inAdult Subjects with Moderate to Severe Hidradenitis Suppurativa

Goldfarb, N.

AbbVie

8/8/19 → 8/30/24

Project: Research project

A PHASE 3 OPEN-LABEL, MULTI-CENTER, LONG-TERM STUDY INVESTIGATING THE SAFETY ANDEFFICACY OF PF-06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA

6/17/19 → 6/30/24

Project: Research project

A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY ANDSAFETY PROFILE OF PF-06651600 WITH A PARTIALLY BLINDED EXTENSIONPERIOD TO EVALUATE THE EFFICACY AND SAFETY OF PF-06651600 ANDPF-067008

6/20/19 → 6/30/24

Project: Research project

Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma

Maher, I.

CASTLE BIOSCIENCES, INC.

2/6/19 → 2/29/24

Project: Research project

A double-blind, randomized, vehicle controlled, crossove

ELORAC INC

10/1/17 → 2/20/24

Project: Research project

Open-Label Study of ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), AlopeciaUniversalis (AU) and Alopecia Totalis (AT)

ACLARIS THERAPEUTICS, INC

1/4/19 → 1/31/24

Project: Research project

Measuring Alopecia Areata Patient-Reported Psychosocial Outcomes: Scale Development and Validation

10/7/20 → 1/31/24

Project: Research project

A Phase 2B/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata (AA) Subjects with 50% or Greater Scalp Hair Loss

10/9/18 → 10/30/23

Project: Research project

A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study ofPatidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal CellCarcinomas (BCCs) in Subjects with Basal Cell Nevus

Maher, I.

PELLEPHARM, INC.

8/27/18 → 8/31/23

Project: Research project

A Multicenter, Randomized, Double-Blind, PlaceboControlled, Operationally Seamless, Adaptive Phase 2/3Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Severe or Very SevereAlopecia Areata

Eli Lilly G.m.b.H.

8/6/18 → 8/30/23

Project: Research project

Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study with 24-monthOpenlabelFollow-up of Oleogel-S10 in Patients with Inherited Epidermolysis Bullosa

AMRYT RESEARCH, LTD

8/30/18 → 8/30/23

Project: Research project

Mechanism of immune modulation by DPCP in alopecia

National Alopecia Areata Foundation

1/1/16 → 6/30/23

Project: Research project

Wearable Device Intervention to Improve Sun Behaviors in Melanoma Survivors

Vogel, R. & Ahmed-Saucedo, R. L.

AMERICAN CANCER SOCIETY, INC.

7/1/19 → 6/30/23

Project: Research project

Effect of mechanical intervention on the scalp microbiome: setting the stage for the future management of cicatricial alopecias

Farah, R. S., Staley, C. & Paiewonsky, B.

AMERICAN ACADEMY OF DERMATOLOGY

5/26/22 → 5/25/23

Project: Research project

Feasibility Study to Evaluate the Safety and Efficacy of Cellular Matrix??? BCT-HA Kit as a New Treatmentfor Dehydrated and Wrinkled Skin (A clinical and histological evaluation)

Regeneron Pharmaceuticals, Inc.

REGEN LAB SA

4/1/22 → 4/15/23

Project: Research project

A Phase 2/3 Study Investigation the Phamacokinetics, Saf

Maguiness, S.

2/1/17 → 2/28/23

Project: Research project

Resident Leadership Academy in Health Equity: a pilot curriculum for a nationwide program in addressing health disparities in dermatology

Jacobsen, A. A.

AMERICAN ACADEMY OF DERMATOLOGY

5/1/22 → 1/27/23

Project: Research project

An Open Label Extension Study to Assess the Long Term Safety and Efficacy of Dupilumab in Patients > 6months to < 18 years of age with Atopic Dermatitis

Maguiness, S.

Regeneron Pharmaceuticals, Inc.

11/1/17 → 11/30/22

Project: Research project

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability andEfficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects with Alopecia Areata,Alopecia Universalis or Alopecia Totalis

ACLARIS THERAPEUTICS, INC

6/15/18 → 6/30/22

Project: Research project

Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficay of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma

National University of Singapore

SOLIGENIX INC

11/27/18 → 5/6/22

Project: Research project

Developing the next generation of safer 2-in-1 hair dye products

Bigliardi, P. L.

12/1/19 → 3/31/22

Project: Research project

A PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,

Farah, R. S. & Hordinsky, M. K.

6/21/17 → 1/30/22

Project: Research project

WEN Shampoo Study

CHAZ DEAN, INC.

8/27/18 → 10/31/21

Project: Research project

An International, Multicenter, Randomized, Double-Blind,

MEDPACE, INC.

8/1/17 → 8/30/21

Project: Research project

A Randomized, Double-blind, Vehicle-controlled

ACLARIS THERAPEUTICS, INC

8/1/17 → 8/30/21

Project: Research project

Multicenter, Randomized, Double-Blind Placebo-Controlled

Allergan, Inc.

3/1/16 → 3/30/21

Project: Research project

Phase IV Randomized Study of Two Dose Levels of Targetin

EISAI MEDICAL RESEARCH INC.

3/18/10 → 12/31/20

Project: Research project

A Randomized, Double-Blind Clinical Trial to Evaluate th

Lexington International, LLC

11/17/09 → 12/31/20

Project: Research project

The Impact of Pediatric Skin Disorders: The "Big" Study

Boull, C. L.

Northwestern University

9/13/19 → 12/31/20

Project: Research project

An Open-Label (Part A) and a Double-Blind, Randomized, P

Incyte Corporation

8/1/15 → 8/30/20

Project: Research project

A PROSPECTIVE OBSERVATIONAL STUDY OF TREATMENT PATTERNS

Bohjanen, K. A. & Lee, P. K.

Genentech Inc.

6/3/13 → 6/30/20

Project: Research project

A Prospective Observational Study of Treatment Patterns

Bohjanen, K. A. & Lee, P. K.

Genentech Inc.

6/3/13 → 6/30/20

Project: Research project

An Open Label Multi-Center Extension Study to Evaluate

SCIODERM, INC.

4/22/16 → 4/30/20

Project: Research project

A Phase 3, Multi-center, Randomized, Double-Blind

Jenkins, M. & Hordinsky, M. K.

SCIODERM, INC.

4/20/16 → 4/30/20

Project: Research project

Skin Dendritic Cells and Humoral Immunity

University of Pittsburgh

9/1/15 → 3/31/20

Project: Research project

APPLES: A prospective, pediatric, longitudinal evaluatio

Astellas Pharma US, Inc.

5/17/05 → 3/31/20

Project: Research project

MASTER A Research Study to Evaluate frontal fibrosing A